Drug Guide
Oxytetracycline
Classification
Therapeutic: Antibiotic, Tetracycline class
Pharmacological: Protein synthesis inhibitor, bacteriostatic
FDA Approved Indications
- Respiratory tract infections
- Urinary tract infections
- Skin infections
- Ophthalmic infections
- Anaplasmosis in cattle and sheep
- Tick fever in dogs
Mechanism of Action
Oxytetracycline binds to the 30S ribosomal subunit, inhibiting the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby preventing protein synthesis and bacterial growth.
Dosage and Administration
Adult: Typically 250 to 500 mg every 6 to 12 hours, depending on infection severity and site.
Pediatric: Dosing based on weight, generally 25-50 mg/kg/day divided into 2-4 doses.
Geriatric: Adjust dose based on renal function, monitor for side effects.
Renal Impairment: Use with caution; dose adjustment may be necessary.
Hepatic Impairment: No specific adjustment recommended; monitor liver function during prolonged therapy.
Pharmacokinetics
Absorption: Orally absorbed with variable bioavailability; better absorption on an empty stomach.
Distribution: Widely distributed in body tissues and fluids, including cerebrospinal fluid and eye tissues.
Metabolism: Minimal hepatic metabolism.
Excretion: Primarily excreted unchanged in urine and feces.
Half Life: Approximately 8-12 hours.
Contraindications
- Allergy to tetracyclines or other related antibiotics.
Precautions
- Use with caution in pregnant women, nursing mothers, and children under 8 due to teeth discoloration and bone growth inhibition.
- Monitor renal and hepatic function during prolonged therapy.
Adverse Reactions - Common
- Gastrointestinal upset (nausea, vomiting, diarrhea) (Common)
- Photosensitivity (Common)
Adverse Reactions - Serious
- Hepatotoxicity (Rare)
- Blood dyscrasias (Rare)
- Superinfection (such as candida) (Rare)
Drug-Drug Interactions
- Concurrent use with retinoids may increase intracranial pressure.
- Calcium, magnesium, aluminum containing antacids and dairy products decrease absorption.
Drug-Food Interactions
- Dairy products, antacids, iron supplements reduce bioavailability.
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for signs of allergic reactions, superinfection, liver and kidney function, gastrointestinal disturbances.
Diagnoses:
- Risk for superinfection
- Impaired gastrointestinal mobility
Implementation: Administer with or without food as tolerated; avoid dairy and antacids around dosing times; monitor labs.
Evaluation: Assess resolution of infection and monitor for adverse effects.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Avoid dairy and antacids close to medication times.
- Report signs of allergic reactions, liver problems, or superinfection.
- Use sunscreen and protective clothing to prevent photosensitivity reactions.
Special Considerations
Black Box Warnings:
- Discoloration of permanent teeth and enamel hypoplasia in children under 8; avoid use unless no alternatives are available.
- Hepatotoxicity and intracranial hypertension in certain populations.
Genetic Factors: No specific genetic considerations noted.
Lab Test Interference: May cause false elevations of urinary catecholamines and serum creatinine.
Overdose Management
Signs/Symptoms: Gastrointestinal distress, dehydration, dizziness, and superinfection.
Treatment: Supportive care, gastrointestinal decontamination if early, and monitoring renal function.
Storage and Handling
Storage: Store at controlled room temperature (20-25°C), away from moisture, heat, and light.
Stability: Stable under proper storage conditions.